RecruitingNCT06120361

The Swedish BioFINDER - Primary Care Study

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Skane University Hospital
Intervention
Plasma APS 2 score(diagnostic_test)
Enrollment
1200 target
Eligibility
40 years · All sexes
Timeline
20202028

Study locations (1)

Collaborators

Lund University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06120361 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease

← Back to all trials